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RECENT ADVANCES
Universal neonatal hearing screening moving from evidence
to practice
C Kennedy, D McCann
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Recent technological advances have made feasible
universal newborn hearing screening and therefore early
detection of permanent childhood hearing impairment.
Over the past three years, new information has been
published on whether early intervention is beneficial, the
possibility of harm arising from newborn screening, and its
cost. Dramatic progress has been made in the large scale
implementation of universal screening in many parts of the
western world.
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A
ny discussion of congenital permanent
childhood hearing impairment (PCHI)
needs to define the term at the outset.
Bilateral PCHI > 40 decibels relative to hearing
threshold level (dB HTL) is the target condition
for which there is the strongest case for screen-
ing on the grounds that treating this condition
early in infancy may reduce the average deficit in
verbal as compared with non-verbal abilities
from 25 intelligence qotient (IQ) points to 6 IQ
points1 and, unless otherwise stated, is the
condition to which ‘‘PCHI’’ refers in this article.
The hypothesis that early detection of PCHI
produces worthwhile benefit in terms of
improved speech and language provides the
rationale for the screening of infants for the
condition that has been undertaken in the
United Kingdom for nearly half a century.
Recent technological advances have made uni-
versal newborn hearing screening (UNHS) fea-
sible and have not only led to a radical revision of
screening methods but also opened the door to
scientific evaluation of the benefit of early
intervention. The enthusiasm of some advocates
of UNHS in North America for the very early
detection of even the mildest of hearing impair-
ments is in contrast with a more sober systematic
review of the topic on behalf of the US Preventive
Services Task Force,2 which provides an excel-
lent recent summary of the current state of
knowledge.
The Current Topic review of this subject in this
journal three years ago3 provides a background
review of the issues, including a brief description
of screening methods. The paragraphs that
follow will focus principally on the many
additional reports in the field that have been
published since then.
There is new evidence on all four of the
questions about translation of evidence into
policy that were raised by Hall and Davis in
their commentary on that review.4 Specifically,
there is new information on whether early
intervention is beneficial, the question of the
possibility of harm arising from newborn screen-
ing, and its cost (but we will not review here the
substantial number of papers on the financial
aspects). Finally, dramatic progress has been
made in large scale implementation of UNHS as
a matter of public policy particularly in the
United Kingdom and also in other parts of
Europe and the United States.
EPIDEMIOLOGY
PCHI affects about 133 per 100 000 population
(95% confidence interval (CI) 122 to 145); 112
are congenital and the remainder comprise
progressive and acquired losses.5 6 Fortnum et
al7 reported that the prevalence of PCHI of this
degree continues to rise until the age of 9 years
and may be as high as 205 per 100 000. The
higher figure, if correct, suggested that progres-
sive losses had previously been greatly under-
estimated. An accompanying editorial pointed
out the need for longitudinal data to address
this.8
This high prevalence, however, depended on
inclusion of an adjustment for supposed under-
reporting. The adjustment, arrived at by compar-
ing reported figures from audiology departments
and education departments and using a capture-
recapture analysis, assumed that these sources
were independent. This assumption was justified
by reference to the small subpopulation of
children who had received cochlear implants,
but it is not likely to be true of the wider
population of children with PCHI, particularly
with respect to their contact with education and
health services.
Reports on the prevalence of PCHI in large
populations of screened infants in the United
States, Australia, and the United Kingdom
appear to support the more conservative figure
of about 133 per 100 000.9–15 The fact that there
are both progressive and acquired losses never-
theless indicates the need for systems to detect
PCHI that develops after the newborn period. For
a more detailed discussion of the epidemiological
issues and their implications, the reader is
referred to Fortnum’s own recent comprehensive
review.16
Abbreviations: AABR, automated auditory brainstem
response; PCHI, permanent childhood hearing
impairment; TEOAE, transient evoked otoacoustic
emission; UNHS, universal newborn hearing screening
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ACCURACY OF UNHS AS ASSESSED IN INFANCY
Eight key criteria for assessing any screening programme
were listed in the previous annotation on neonatal screen-
ing.3 One of these is the existence of a screening test that
accurately identifies children who may have an impairment.
The most important indicators of a screen’s accuracy are its
sensitivity and specificity. In this case these are measures of
the screen’s ability to identify infants with PCHI and those
without PCHI respectively.
These tests can be assessed with respect to either the
population that received a screening test or the larger
population that was the target for screening for respective
calculation of either the test or the programme sensitivity.
The implications of a screening programme are also affected
by the prevalence of the target condition. This is captured in
additional measurements such as the positive predictive
value, which is the probability that a case that screens
positive will prove to have the target condition, and the
positive likelihood ratio, a comparison of the odds of being a
case after screening positive with the odds of being a case
before screening.
In the case of PCHI, making these measurements is not
straightforward. Estimates of sensitivity require ascertain-
ment of all true cases, which is not possible until school age.
They will include some cases of ‘‘progressive’’ loss and will
not include audiology assessment of all those who screen
negative. However, attempts to overcome these problems
have been made (see next section). Many studies have
avoided these problems by using a marker of process as a
proxy measure of sensitivity. Incremental yield, the increase
in the yield of the number of referrals of true cases, is an
example of a proxy measure of sensitivity.
Estimates of specificity are easier to make but include the
assumption that detection of ‘‘false positive’’ cases of mild,
unilateral, or non-permanent hearing impairment is no more
desirable than a false positive screen in a child with normal
hearing.
Most programmes use a two step screen in which an infant
who shows ‘‘no clear response’’ on the initial test undergoes a
second test soon after the first, and, if the second test also
shows no clear response, is referred for audiology evalua-
tion (fig 1A–C). The principal neonatal screening tests
are detection of transient evoked otoacoustic emissions
(TEOAEs) and automated auditory brainstem response
(AABR) testing. The screen consists of either repetition of
one of these tests or sequential use of the two different
methods either in all babies or, in other applications, only if
the first test gives no clear response. A brief explanation of
these methods is given in the previous annotation,3 a more
detailed description of their relative merits by Watkin,17 18
and a comparison of one and two stage screens formed part
of the New York State UNHS demonstration project.19
Watkin’s recent review18 of these methods is a very clear
account.
So how accurate is UNHS? Only two studies of the
accuracy of UNHS were rated as being of good quality in a
comprehensive systematic review of 864 articles on UNHS in
2000.2 The only controlled trial of UNHS reported that the
yield of true cases of PCHI referred before 6 months of age
was 32 per 100 000 in periods without and 94 per 100 000 in
periods with UNHS, an increase of 62 cases per 100 000
target population.13 The other study of ‘‘good quality’’,
according to the systematic review, was the New York State
UNHS statewide ‘‘demonstration project’’. This study
reported a yield of 68 per 100 000 target population from
UNHS.11 There was no comparison group to estimate the yield
without UNHS. In that project, the mean (median) age of
diagnosis was 3.5 (2.5) months for mild or moderate PCHI
and 6.3 (3.8) months for severe PCHI. Developmental delay,
non-attendance for follow up, and transient conductive
losses delayed diagnosis until the second year of life in about
40% of cases.
The use of a reliable behavioural test of hearing, such as
pure tone audiometry, in the entire population of children
who had received UNHS would be necessary to estimate
directly the sensitivity of UNHS to PCHI in infancy but the
low prevalence of PCHI means that tens of thousands of
audiograms would be required to produce reliable figures. No
such study has been done except in a population of graduates
of neonatal intensive care units. The higher risk of PCHI in
this group reduced the number of audiograms required to
produce reliable estimates of its prevalence.
These babies were neonatally screened using TEOAEs
followed by AABR in a study in Seattle and later evaluated
with visual reinforcement audiometry at the age of 8–
12 months.20 ‘‘Hit rates’’ for the neonatal tests, in general,
exceeded 80% when the false alarm rate was fixed at 20% and
hearing impairment was defined as behavioural thresholds
. 30 dB HL. This is a lesser degree of PCHI than has been
used in the definition of the target condition for UNHS in the
United Kingdom. As the hit rate increased in the Seattle
study as the severity of hearing loss increased, these figures
are encouraging evidence of the sensitivity of the neonatal
screen in high risk infants.
The UK national protocol (www.nhsp.info)21 recommends
TEOAE detection followed by AABR testing as a two step
Figure 1 (A) Baby with ear probe for detection of transient evoked
otoacoustic emissions (TEOAEs). (B) Testing at the bedside using
‘‘ILO88’’ PC based software to distinguish ‘‘clear response’’ from ‘‘no
clear response’’ on TEOAE testing. (C) Baby with ear coupler and scalp
electrodes for ‘‘Algotek’’ automated auditory brain stem response
testing, used as second stage of two stage screening protocol.
Newborn hearing screening F379
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screen. It recommends that all babies nursed on neonatal
intensive care units for more than 48 hours should have both
tests, whereas ‘‘well babies’’ should only proceed to AABR if
TEOAEs were not detectable in one (or both) ears in the first
step of the screen (fig 2A,B).
An alternative strategy would be to tailor the threshold for
screening positive according to the age at screening and to
the risk status of the baby. For example, one study classified
detection of TEOAEs in one ear as a negative screen in babies
screened less than 48 hours after birth but required bilateral
TEOAE detection to fulfil criteria for screening negative in
babies screened at a greater postnatal age.22 In the same
study, amending the protocol to redefine a positive screen, in
the babies at low risk13 only, as bilateral (rather than
unilateral) failure on AABR testing (the second step of the
screen) significantly reduced the overall false alarm rate from
1.15% to 0.56% without reducing the yield of true cases of
PCHI from the screen.
That study provided a simple summary of the ‘‘accuracy’’
of this newborn screen as follows: of those screening positive
on this protocol, a quarter (0.17% of those screened) had the
target condition of PCHI, a quarter (0.17% of those screened)
had non-targeted (non-permanent, mild, or unilateral)
hearing impairments, and a half (0.34% of those screened)
had normal hearing.22 The subsequent estimate of sensitivity
from the same study suggests that, of those screening
negative, less than 1 in 10 000 will subsequently prove to
have a PCHI23 (see next section). These figures are very
acceptable when screening for a condition of relatively high
prevalence and exemplify achievable standards for accuracy
of UNHS with which other implementations could be
compared. They depend on setting the threshold for screen-
ing positive at a level high enough to keep specificity high but
low enough not to compromise sensitivity.
UNHS programmes have also been introduced in other
parts of Europe,24 the United States,9 11 20 and Australia.25 The
effectiveness of many programmes in the United States has
been limited by poor rates of screening and attendance for
rescreen and for audiology evaluation after ‘‘no clear
response’’ on UNHS. A study in Rhode Island, the first state
in the United States to establish a state wide programme of
UNHS, has shown that this is heavily dependent on socio-
economic and demographic variables: those with traditional
Medicaid insurance were less likely to be screened or to be
rescreened.26
ACCURACY OF UNHS AS ASSESSED LATER IN
CHILDHOOD
Not all school age PCHI is detectable in infancy. As well as
those cases in which negative screening in the neonatal
period or later in infancy is misleading because deafness was,
in fact, present, there are some cases in which the neonatal
screen was correct but genetically determined or prenatally
acquired PCHI subsequently progressively worsens with age
(see section on epidemiology above), and others in which
deafness is postnatally acquired. Consequently, the sensitivity
of UNHS to childhood PCHI is lower than to infantile PCHI.
Follow up data derived from population based birth
cohorts that were the target of UNHS are very sparse.
Longitudinal study of the three year birth cohort enrolled in
the Wessex trial13 now allows estimation of the sensitivity of
the UNHS programme for all cases of PCHI still present in the
population at the age of 7–9 years.23 Information from a
number of professional and other sources indicated that the
prevalence of PCHI in these children at 7–9 years of age was
about 125 per 100 000 both in populations that were and
were not the target of UNHS. In the half of the trial birth
cohort that was the target for UNHS, sensitivity of UNHS to
PCHI at 7–9 years was 56%. Of all such cases, 58% had been
referred (from UNHS or other source of referral) before the
age of 6 months. These figures compare well with the
equivalent respective figures of 14% and 16% in the half of
the trial birth cohort that was not the target for UNHS. Test
sensitivity of UNHS was, nevertheless, high at 30/32 (94%)
cases. In other words, only two of the 32 cases (eight per
100 000 target population) of PCHI in the population at 7–
9 years of age had actually received UNHS and shown a clear
response—that is, screened negative—yet subsequently been
found to have PCHI. Watkin18 has reported 81% programme
sensitivity and 94% test sensitivity of UNHS on the basis of
longitudinal follow up to school age.
DELETERIOUS EFFECTS OF UNHS
To identify a single confirmed case of PCHI by UNHS, nearly
1000 infants will be tested, and between five and 40 will
show ‘‘no clear response’’ on UNHS. It is therefore important
to show a very low incidence of harmful effects from
screening. Recent publications7 18 27 28 have confirmed the
earlier reports29 30 showing positive effects and no increase in
anxiety in the vast majority of families. The anxiety and other
adverse effects seen in a very few can be avoided or
minimised both by increasing the quantity and quality of
presentation of information—for example, use of ‘‘no clear
response’’ in preference to ‘‘fail’’—and also by decreasing
false alarm rates. False alarm rates can be reduced by
adapting screening tools to the age at screening and risk
status of the baby (see section on accuracy above).
EFFECT OF EARLY INTERVENTION ON SPEECH AND
LANGUAGE
The deleterious effect of bilateral PCHI on speech and
language is well established.2 5 31 32 Language quotients of
160 infants enrolled in the Colorado Home Intervention
Program at a mean age of 26 months were reported to be
substantially higher in those identified between birth and
6 months than in those identified subsequently (mean (SD)
79.0 (20.9) v 63.8 (19.3), p , 0.001), with little effect of the
severity of PCHI on the magnitude of the difference.1 Those
identified between 6 and 12 months fared no better than
those diagnosed later. More recent reports from the same
group have compared language quotients between children
born in hospitals with and without UNHS programmes.34
They have summarised the results of their programme of
research from 1994 to 2001.33 Mean language scores were 18–
21 points higher and within the normal range for the
neonatally screened group.
The all or nothing nature of the reported benefit of very
early intervention reported from the Colorado programme
has catalysed the introduction of UNHS in the United States,
but the studies of these children are open to a number of
criticisms and were rated as ‘‘poor quality’’ in the systematic
review.2 In the earlier study,1 the later identified group was
characterised by mothers of lower educational achievement
and babies with more severe hearing loss and greater
likelihood of non-verbal cognitive impairment and use of
sign language, but the analysis did not allow simultaneous
adjustment for all of these factors.
There was no information about the whole population of
children with hearing impairment nor about children whose
families had taken them out of the service before the study.
In the more recent study,34 eligibility for the screened group
was conditional on an assessment of language being
available, the two groups were drawn from different hospitals
at different times, selection of subjects and assessment of
outcome were unblinded, and the number of and reasons for
exclusion were not reported. Outcome measures relied
heavily on parent reports, which are open to bias. Finally
the fact that outcomes were assessed in the preschool years
F380 Kennedy, McCann
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means that measurement of non-verbal IQ was difficult and
likely to lack stability over time, and that it was too soon to
assess catch up progress in verbal abilities among those
treated later.
Benefits of early intervention were also reported in an
uncontrolled sample of 112 children aged 5 years enrolled in
the Diagnostic Early Intervention Program in Nebraska.35
Those with cognitive abilities less than 70 and non-
participants in the programme were excluded. Age of
enrolment in the programme accounted for 11.5% of the
variance in vocabulary, and family involvement in treatment
(assessed on a simple rating scale) accounted for 57% of the
variance in a multiple regression analysis that also included
non-verbal IQ. Rates of attrition from the study were not
reported. Children with poor family involvement and late
enrolment had poor speech and language outcomes, whereas
good family involvement appeared to protect children from
the deleterious effects of being enrolled late.
A population based study of all children in the state of
Victoria, Australia with congenital PCHI reported on outcome
at 7–8 years, an average interval of 6.1 years from diagnosis.31
All such children who were fitted with hearing aids by
4.5 years and without intellectual disability or a serious
medical condition were eligible for inclusion. Outcomes were
reported on 89 respondents from 132 eligible children from
the entire three year birth cohort from a state population of
Figure 2 (A) Decision chart for UK national screening protocol: well babies. (B) Decision chart for screening protocol: babies in neonatal intensive
care unit (NICU) for more than 48 hours.
Newborn hearing screening F381
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4.8 million. Respondents were similar to non-respondents, so
the findings should be generalisable. The mean age at which
hearing aids were fitted was 1.9 years. These children and
their parents completed a battery of assessments of language,
articulation, cognition, reading, adaptive functioning, health
related quality of life, behaviour, and school functioning.
The sample scored far (1.3–1.7 standard deviations) below
the normal population on language scores. Outcomes were
significantly worse on every outcome measure except
physical health. Mean language and vocabulary scores, but
not other outcome measures, fell sharply with increasing
severity of hearing impairment adjusted for age at diagnosis
and non-verbal IQ.36 By contrast, there was no significant
correlation between age at diagnosis or age at treatment and
any of the outcome measures. Family functioning did not
correlate with any outcome measure, and socioeconomic
factors were only weakly related to outcome measures. In a
general linear model, estimated mean language and reading
scores did not vary significantly by age of diagnosis adjusted
for severity of PCHI and non-verbal IQ. Eleven children in the
sample were diagnosed before the age of 6 months and their
outcome was no better than the further 17 diagnosed
between 6 and 12 months or the 55 diagnosed later.36
This careful population based study thus showed the
opposite result to that reported in children of similar age
reported by Moeller.35 This must cast doubt on the
generalisability of the two service based American studies.1 35
The main weakness of the Australian study is the relatively
small numbers of children diagnosed in the first 6 months of
life: although the study found no evidence of benefit in these
children, the confidence intervals around this observation are
wide.
A UK study of design similar to that of the Australian study
will report in 2005 on speech and language and other
outcomes in a cohort of over 100 children with PCHI born
between 1993 and 1996 and a comparison group of normally
hearing children. The children were drawn from the Wessex
trial birth cohort, half of whom received UNHS, the Waltham
Forest and Hillingdon birth cohorts that were the target for
UNHS, and their two respective neighbouring districts that
were not. Our preliminary analysis of language outcomes in
this population, after adjustment for severity of PCHI, non-
verbal intelligence, and maternal educational level, confirms
significantly improved language skills at 7–10 years in
children whose PCHI was confirmed before the age of 10
months compared with those in children whose PCHI was
confirmed at a greater age (www.nhs2004.polimi.it).
In summary, there is some preliminary evidence for
improved language outcomes following ‘‘earlier’’ interven-
tion, but as yet this is inconclusive with respect to the
threshold age by which intervention should begin and
interrelations between age at intervention and other impor-
tant explanatory variables such as severity of PCHI, non-
verbal ability, family participation, and the nature of the
intervention. Population based investigations of children of
primary school age may help to clarify the benefit of early
intervention on outcomes for children with PCHI.
IMPLEMENTATION OF UNHS AS NATIONAL POLICY
IN THE UNITED STATES AND THE UNITED KINGDOM
Between 1993 and 2000, the number of hospitals in the
United States that screened more than 90% of newborns for
hearing loss increased from 11 to about 1000. Thirty two
states have ‘‘mandated’’ UNHS by law, although the funding
arrangements to support this are often problematic. Age of
intervention is falling in successive birth cohorts, and the fall
is associated with UNHS programmes.37 The comprehensive
critical review commissioned by the Department of Health
(DoH), published in 19975 and summarised in this journal,38
set in train the process, which has led to a national change in
practice in the United Kingdom. In 2001, the DoH commis-
sioned a national programme of UNHS and linked its
implementation to a systematic evaluation of the first 23
sites with a view to involving the whole of the United
Kingdom in the programme by April 2006. Major innovations
in services are being developed to produce family friendly
hearing services in which health education and voluntary and
social services provide an equitable and seamless service for
children with PCHI and their families. In particular, the
Department for Education and Skills (DfES), working with
the Royal National Institute for Deaf People, has devised new
strategies for working with children under the age of 2 years
for which the DfES previously had no mandate, and Early
Excellence Centres have been developed to promote multi-
disciplinary input to all stages of management.21
Hall and Davis4 summarised the frustrations experienced
in the late 1990s by those involved in trying to bring these
changes about. They drew attention to the fact that the
heavily centralised decision making process in the United
Kingdom lacked clarity as to how the findings of a critical
review may influence policy and that the children’s subgroup
of the national screening committee lacked the authority to
turn policy into action. There were no funds available to
allow the questions raised by the systematic review to be
addressed in a timely fashion, no defined way in which the
views of the consumer, as represented by voluntary organisa-
tions, could be incorporated into policy making, and no
commitment from the government to respond to the advice
of professional committees.
Between 2000 and 2003, however, frustration seems to
have given way to a stream of creative and sometimes radical
change supported by (at least some) government funding.
Visitors to the newborn hearing screening programme web
site (www.nhsp.info) cannot fail to be impressed by the
wealth of information available in menus, submenus, down-
loadable pdf files for parents and professionals, PowerPoint
presentations, information sheets in many languages, news-
letters, links to other sites such as the DfES early support
pilot programme site (www.espp.org.uk), and so on. A
process of dynamic change is already well advanced. Web
page feedback on the current performance of the programme
included the following statistics: for the pilot sites up to 31
May 2003, 121 253 infants had been screened, 2341 referred
from the screen, and 121 cases of bilateral hearing loss
confirmed, a yield of 100 per 100 000, a figure remarkably
similar to that reported in the Wessex Trial.13 The coverage
rate from all sites is reported to be 96% overall. This is a quite
astonishing achievement. This figure included data from two
pilot sites that reported coverage of 98% using community
based screening, for which the pre-existing evidence base
was very slender.39 It remains to be seen whether community
based screening is generalisable in the same way that
hospital based screening has proved to be.
Introduction of UNHS has immediate implications for
information (assisted by the recent introduction of NHS
number allocation at birth), equipment, and the development
of information technology. In addition, there are major
implications for the development and quality of paediatric
hearing services, education, and social services. Quality
assurance will be based around peer review of services
achieved by continuous audit and a three yearly programme
of visits by practising professionals in health, education, and
social services and parent representatives.
It seems probable that in five years from now, at least two
thirds of all cases of PCHI in childhood will be diagnosed
before the age of 6 months and that the profile of service
provision to support children with such impairments will
have undergone radical change compared with that available
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five years ago. Achievement of this will depend on financial
support to meet the demand for new kinds of service that will
increase as early detection following UNHS becomes the
norm throughout the United Kingdom. Although it will be
some time before reliable estimates of cost effectiveness are
available, it seems likely that this change will have reduced
the burden to families and education of speech and language
impairments and their secondary consequences. This is
something to celebrate.
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